1. A matching-adjusted indirect treatment comparison (MAIC) of daratumumab–bortezomib–melphalan–prednisone (D-VMP) versus lenalidomide–dexamethasone continuous (Rd continuous), lenalidomide–dexamethasone 18 months (Rd 18), and melphalan–prednisone–thalidomide (MPT). Issue 3 (23rd February 2020) Authors: Dimopoulos, Meletios A.; Cavo, Michele; Mateos, Maria-Victoria; Facon, Thierry; Heeg, Bart; van Beekhuizen, Sophie; Gebregergish, Samron B.; Nair, Sandhya; Pisini, Marta; Lam, Annette; Slavcev, Mary Journal: Leukemia & lymphoma Issue: Volume 61:Issue 3(2020) Page Start: 714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study. Issue 10245 (18th July 2020) Authors: Dimopoulos, Meletios; Quach, Hang; Mateos, Maria-Victoria; Landgren, Ola; Leleu, Xavier; Siegel, David; Weisel, Katja; Yang, Hui; Klippel, Zandra; Zahlten-Kumeli, Anita; Usmani, Saad Z Journal: Lancet Issue: Volume 396:Issue 10245(2020) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study. Issue 1 (January 2022) Authors: Usmani, Saad Z; Quach, Hang; Mateos, Maria-Victoria; Landgren, Ola; Leleu, Xavier; Siegel, David; Weisel, Katja; Gavriatopoulou, Maria; Oriol, Albert; Rabin, Neil; Nooka, Ajay; Qi, Ming; Beksac, Meral; Jakubowiak, Andrzej; Ding, Bifeng; Zahlten-Kumeli, Anita; Yusuf, Akeem; Dimopoulos, Meletios Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Issue 2 (28th January 2023) Authors: Nahi, Hareth; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Oriol, Albert; Plesner, Torben; Bandyopadhyay, Nibedita; Hellemans, Peter; Tromp, Brenda; Nnane, Ivo; Zemlickis, Donna; Chari, Ajai; Moreau, Philippe Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Issue 12 (December 2021) Authors: Ludwig, Heinz; Sonneveld, Pieter; Facon, Thierry; San-Miguel, Jesus; Avet-Loiseau, Hervé; Mohty, Mohamad; Mateos, Maria-Victoria; Moreau, Philippe; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Engelhardt, Monika; Driessen, Christoph; Cook, Gordon; Dimopoulos, Melitios A; Gay, Francesca; Ein... Journal: Lancet Issue: Volume 8:Issue 12(2021) Page Start: e934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial. Issue 6 (June 2021) Authors: Dimopoulos, Meletios A; Terpos, Evangelos; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Baldini, Luca; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria-Victoria; Einsele, Hermann; Orfanidis, Ioannis; Ahmadi, Tahamtan; Ukropec, Jon; Kampf... Journal: Lancet oncology Issue: Volume 22:Issue 6(2021) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Issue 8 (August 2016) Authors: Kumar, Shaji; Paiva, Bruno; Anderson, Kenneth C; Durie, Brian; Landgren, Ola; Moreau, Philippe; Munshi, Nikhil; Lonial, Sagar; Bladé, Joan; Mateos, Maria-Victoria; Dimopoulos, Meletios; Kastritis, Efstathios; Boccadoro, Mario; Orlowski, Robert; Goldschmidt, Hartmut; Spencer, Andrew; Hou, Jian; Ch... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: e328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Melflufen for the treatment of multiple myeloma. Issue 4 (3rd April 2022) Authors: Ocio, Enrique M.; Nadeem, Omar; Schjesvold, Fredrik; Gay, Francesca; Touzeau, Cyrille; Dimopoulos, Meletios A.; Richardson, Paul G.; Mateos, Maria-Victoria Journal: Expert review of clinical pharmacology Issue: Volume 15:Issue 4(2022) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study. Issue 2 (February 2022) Authors: Schjesvold, Fredrik H; Dimopoulos, Meletios-Athanasios; Delimpasi, Sosana; Robak, Pawel; Coriu, Daniel; Legiec, Wojciech; Pour, Luděk; Špička, Ivan; Masszi, Tamas; Doronin, Vadim; Minarik, Jiri; Salogub, Galina; Alekseeva, Yulia; Lazzaro, Antonio; Maisnar, Vladimir; Mikala, Gábor; Rosiñol, Laura;... Journal: Lancet Issue: Volume 9:Issue 2(2022) Page Start: e98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma. (3rd October 2022) Authors: Costa, Luciano J.; Hari, Parameswaran; Berdeja, Jesus G.; De Stefano, Valerio; Gay, Francesca; Hooper, Becky; Bartlett, Meaghan; Haltner, Anja; Rosta, Emily; Kumar, Shaji; Martin, Thomas; Mateos, Maria-Victoria; Moreau, Philippe; Usmani, Saad Z.; Olyslager, Yunsi; Schecter, Jordan M.; Roccia, Tit... Journal: Current medical research and opinion Issue: Volume 38:Number 10(2022) Page Start: 1759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗